page content university navigation catalog navigation footer
Cover Photo 2007-2008 Catalog Online

Course Descriptions:






 

Previous | Next


Pharmacy Practice (PHP)

Chairperson: Professor Owens

311 Foundations of Human Disease I: Immunoinflammatory Disease

See Biomedical and Pharmaceutical Sciences 311.

312 Foundations of Human Disease II: Central Nervous System Disease

See Biomedical and Pharmaceutical Sciences 312.

316 Pharmacy Law and Ethics (3)

Basic principles of law and ethics as applied to federal, state, and local acts, regulation, and practices encountered in professional practice. Specific attention to liabilities of pharmacists in decisions; actions involving sale of medicinals, poisons, narcotics. (Lec. 2. Rec. 1) Pre: third-year standing or permission of instructor.

324 Pharmacotherapy of CNS and Musculoskeletal Disorders—Therapeutics I (2)

The appropriate use of medications in the treatment of human disease. Interpretation of data to design, monitor, and modify drug therapy in psychiatric, neurologic, and musculoskeletal diseases. (Lec. 2) Pre: third-year standing or permission of instructor.

350, 351 Introductory Practice Experience I and II (0)

Structured practical experience in institutional and community pharmacy settings. (Practicum) Pre: third-year standing.

360 Hospital Pharmacy (3)

Introduction to practice of pharmacy in hospitals, including both professional and administrative activities. Field trips to representative hospital pharmacies. (Lec. 3) Pre: third-year standing.

409 Foundations of Human Disease III: Infectious and Pulmonary Processes

See Biomedical and Pharmaceutical Sciences 409.

410 Foundations of Human Disease IV: Endocrinology, Oncology, Medicinal Genetics, GI

See Biomedical and Pharmaceutical Sciences 410.

411 Biostatistics II

See Statistics 411.

413 Pharmacotherapy of Infectious Diseases—Therapeutics II (2)

The appropriate use of medications in the treatment of human disease. Interpretation of clinical data to design, monitor, and modify drug therapy in infections and pulmonary diseases. (Lec. 2) Pre: fourth-year standing or permission of instructor.

414 Pharmacotherapy of Endocrine and GI Disorders—Therapeutics III (2)

The appropriate use of medications in the treatment of human disease. Interpretation of clinical data to design, monitor, and modify drug therapy in endocrine and gastrointestinal disease. (Lec. 2) Pre: fourth-year standing or permission of instructor.

420 Biotechnology Products in Pharmacy

See Biomedical and Pharmaceutical Sciences 420.

430 Advanced Infectious Diseases and Pulmonary Pharmacotherapy (3)

Advanced topics in infectious diseases and pulmonary pharmacotherapy through literature review, data interpretation, and case scenarios. Content will be delivered through the perspective of clinical pharmacists. (Lec. 3) Pre: 413. Not for graduate credit.

440 Advanced Pediatric Pharmacotherapy (3)

Pharmacotherapeutic needs of infants, children, and adolescents with a focus on pharmacokinetic, pharmacodynamic, and other developmental-associated physiological changes. (Lec. 3) Pre: fourth-year standing (second professional year) in the Doctor of Pharmacy program.

450, 451 Introductory Practice Experience III and IV (0)

Structured practical experience in institutional and community pharmacy settings. (Practicum) Pre: fourth-year standing. Not for graduate credit.

460 Palliative Care (3)

Principles of palliative care including control of pain and other symptoms, and psychological, social, and spiritual issues. (Lec.3) Pre: fourth- or fifth-year standing in Pharm.D. program or permission of instructor. Not for graduate credit.

497, 498 Special Problems (1-3 each)

Methods of carrying out a specific research project. Literature search, planning, laboratory work, writing an acceptable report. (Independent Study) Pre: permission of chairperson.

503 Health Systems I (2)

Introduction to the principles of financial analysis, personal management, pharmaceutical marketing, organizational behavior, inventory control, and health policy. Principles as they relate to health care delivery with an emphasis on planning systems. (Lec. 2) Pre: fifth-year standing or permission of instructor.

504 Health Systems II (3)

Analysis and interpretation of the health care delivery system from the perspectives of organizational structure and program analysis. Emphasis on pharmacoeconomic aspects of quality of life issues, outcome measurements, reimbursement systems, and drug utilization evaluation. (Lec. 3) Pre: fifth-year standing or permission of instructor

510 Foundations of Human Disease V: Renal and Cardiovascular Diseases

See Biomedical and Pharmaceutical Sciences 510.

513 Pharmacotherapy of Oncology and Toxicology—Therapeutics IV (2)

The appropriate use of medications in the treatment of human disease. Interpretation of clinical data to design, monitor, and modify drug therapy in cancer, blood disorders, and overdose conditions. (Lec. 2) Pre: fifth-year standing or permission of instructor.

514 Pharmacotherapy of Renal and Cardiovascular Disorders—Therapeutics V (2)

The appropriate use of medications in the treatment of human disease. Interpretation of clinical data to design, monitor, and modify drug therapy in renal and cardiovascular disease. (Lec. 2) Pre: fifth-year standing or permission of instructor.

515 Pharmacy Practice Laboratory I

See Biomedical and Pharmaceutical Sciences 515.

516 Pharmacy Practice Laboratory II

See Biomedical and Pharmaceutical Sciences 516.

518 Self-Care I

See Biomedical and Pharmaceutical Sciences 518.

519 (or BPS 519) Self-Care II (3)

Expansion of nonprescription and complementary medicine therapeutics. Explore the implementation of pharmaceutical care programs in community pharmacy practice. (Lec. 3) Pre: 518 (or BPS 518); fifth-year standing.

520 Advanced Gastrointestinal and Endocrine Pharmacotherapy (3)

Provides students with an expanded knowledge base in the area of GI and endocrine pharmacotherapy, emphasizing active learning, literature evaluation, data interpretation. (Lec. 3) Pre: fifth-year standing in the Doctor of Pharmacy Program; enrollment in the pharmacotherapy track, or permission of instructor. Not for graduate credit.

540 Principles, Methods, and Applications of Epidemiology (3)

An introduction to epidemiology, the study of health and disease in populations. Epidemiologic methods and research design for conducting and interpreting health research. (Lec. 3) Pre: STA 307 or permission of instructor.

542 Evaluation of Controversies in Drug Literature (3)

Through critical review of literature, controversies in drug therapy and drug-associated illness will be evaluated to improve students’ knowledge and analytical skills. (Lec. 3) Pre: fourth-year standing in the College of Pharmacy, or permission of instructor.

550 Pharmacoepidemiology (3)

The application of epidemiologic principles to the study of drug effects in human populations. (Lec. 3) Pre: 540 or permission of instructor.

555 Advanced Neuropsychiatric Pharmacotherapy (3)

Comprehensive and advanced course on the pharmacotherapy of psychiatric and neurological diseases. Use of clinical case studies, evaluation of the primary literature, and other forms of interactive teaching will be emphasized. (Lec) Pre: 324, 312 or BPS 312, BPS 322 or permission of the instructor.

560 Advanced Cardiovascular and Renal Pharmacotherapy (3)

Advanced assessment and pharmacotherapeutic management of patients with cardiovascular and renal disease through the application of evidence-based medicine and critical evaluation of literature. (Lec. 3) Pre: fifth-year standing in the Doctor of Pharmacy Program; enrollment in the pharmacotherapy track, or permission of instructor. Not for graduate credit.

570 Case Studies in Pharmacy Law (3)

Case studies and a detailed analysis of the FDC, Controlled Substances Act, and health insurance laws. (Lec. 3) Pre: 351.

580 Pharmacoeconomic Analysis (3)

Introduction to methodologic approaches utilized in economic evaluation of drug use and therapy in community and managed care settings, and clinical trials, including the FDA approval process and liability issues. (Lec. 3) Pre: STA 307 or equivalent, or permission of instructor. In alternate years.

591 Advanced Outpatient Practice Experience (5)

Students will develop and learn clinical skills to provide pharmaceutical care for patients in either the community or outpatient setting through direct patient contact, use of physical assessment findings, and the design and implementation of patient-specific pharmacotherapy. (Practicum) Pre: sixth-year standing in the Doctor of Pharmacy Program and completion of all required courses in the first 5 years of the program.

592 Advanced Inpatient Practice Experience (5)

Through collaboration with other health care professionals, daily rounding with the medical team, and application of evidence-based medicine, students will develop clinical skills to provide pharmaceutical care for patients in the inpatient setting. (Practicum) Pre: sixth-year standing in the Doctor of Pharmacy Program and completion of all required courses in the first 5 years of the program.

593 Advanced Practice Experience Elective (5)

Students will collect and interpret data to design, recommend, and modify patient-specific pharmacotherapy or pharmaceutical problems in specialized settings in collaboration with other health care professionals. (Practicum) Pre: sixth-year standing in the Doctor of Pharmacy Program and completion of all required courses in the first 5 years of the program.

599 Master’s Thesis Research

Number of credits is determined each semester in consultation with the major professor or program committee. (Independent Study) S/U credit.

640 Epidemiologic Methods for the Health Sciences (2)

A focus on quantitative methods used in epidemiologic and health-related research. Students will learn to analyze and interpret data from large-scale observational studies and will be exposed to problematic situations in research design and data analysis. (Lec. 3) Pre: 540, STA 412, or permission of instructor.

680 The Legal Environment in Health Administration (3)

Application of specialized statutory and regulatory provisions in federal and state law to the delivery of health care. (Lec. 3) Pre: graduate standing.

693, 694 Seminar (1 each)

Seminar discussions including presentation of papers on selected topics in pharmacy. (Seminar) Required of all graduate students, with a maximum of 1 credit allowed per year. May be repeated for a maximum of 2 credits for M.S. candidates. May be repeated for a maximum of 5 credits for Ph.D. candidates.

697, 698 Research (1-3 each)

Literature survey, laboratory work, and a detailed research report on one or more assigned topics in pharmacy. (Independent Study)

699 Doctoral Dissertation Research

Number of credits is determined each semester in consultation with the major professor or program committee. (Independent Study) S/U credit.

900 Physical Assessment (0)

Provides students with an introduction to core patient assessment skills. Further develops students’ patient interviewing and documentation skills. (Workshop) Pre: fifth-year standing in the Doctor of Pharmacy Program. S/U only.


Top | Previous | Next